Cytosolic Delivery of Thiolated Neoantigen Nano‐Vaccine Combined with Immune Checkpoint Blockade to Boost Anti‐Cancer T Cell Immunity

Cytosolic Delivery of Thiolated Neoantigen Nano‐Vaccine Combined with Immune Checkpoint Blockade to Boost Anti‐Cancer T Cell Immunity

Abstract Although tumor‐specific neoantigen‐based cancer vaccines hold tremendous potential, it still faces low cross‐presentation associated with severe degradation via endocytosis pathway. Herein, a thiolated nano‐vaccine allowing direct cytosolic delivery of neoantigen and Toll like receptor 9 ag...

Full description

Bibliographic Details
Main Authors: Da Zhang, Ziguo Lin, Ming Wu, Zhixiong Cai, Youshi Zheng, Lei He, Zhenli Li, Jie Zhou, Liqin Sun, Geng Chen, Yongyi Zeng, Juan Li, Jingfeng Liu, Huanghao Yang, Xiaolong Liu
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Advanced Science
Subjects:
cytosolic delivery
immune checkpoint
neoantigen
T‐cells immunity
thiolated nano‐vaccine
Online Access:https://doi.org/10.1002/advs.202003504

Internet

https://doi.org/10.1002/advs.202003504

Similar Items